News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,134 Results
Type
Article (31823)
Company Profile (11)
Press Release (139300)
Multimedia
Podcasts (4)
Webinars (9)
Section
Business (51990)
Career Advice (364)
Deals (3232)
Drug Delivery (8)
Drug Development (23795)
Employer Resources (32)
FDA (3310)
Job Trends (3168)
News (80313)
Policy (4157)
Tag
Academia (2401)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (20)
Alliances (10854)
ALS (27)
Alzheimer's disease (523)
Antibody-drug conjugate (ADC) (21)
Approvals (3337)
Artificial intelligence (55)
Autoimmune disease (1)
Automation (4)
Bankruptcy (18)
Best Places to Work (2656)
BIOSECURE Act (3)
Biosimilars (8)
Biotechnology (13)
Bladder cancer (24)
Brain cancer (9)
Breast cancer (85)
Cancer (631)
Cardiovascular disease (40)
Career advice (337)
Career pathing (9)
CAR-T (44)
Cell therapy (113)
Cervical cancer (6)
Clinical research (18510)
Collaboration (165)
Compensation (10)
Complete response letters (1)
COVID-19 (1175)
CRISPR (12)
C-suite (152)
Cystic fibrosis (23)
Data (752)
Decentralized trials (1)
Denatured (3)
Depression (6)
Diabetes (55)
Diagnostics (1654)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (23)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (20)
Earnings (6290)
Editorial (6)
Employer branding (2)
Employer resources (29)
Events (17624)
Executive appointments (463)
FDA (3560)
Frontotemporal dementia (4)
Funding (202)
Gene editing (33)
Generative AI (4)
Gene therapy (77)
GLP-1 (125)
Government (941)
Guidances (3)
Healthcare (5024)
Huntington's disease (2)
IgA nephropathy (8)
Immunology and inflammation (10)
Indications (9)
Infectious disease (1208)
Inflammatory bowel disease (41)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (19)
Interviews (41)
IPO (1472)
IRA (6)
Job creations (575)
Job search strategy (315)
Kidney cancer (5)
Labor market (6)
Layoffs (34)
Leadership (2)
Legal (678)
Liver cancer (21)
Lung cancer (83)
Lymphoma (48)
Machine learning (2)
Management (9)
Manufacturing (38)
MASH (25)
Medical device (3032)
Medtech (3033)
Mergers & acquisitions (1809)
Metabolic disorders (121)
Multiple sclerosis (19)
NASH (5)
Neurodegenerative disease (26)
Neuropsychiatric disorders (1)
Neuroscience (649)
NextGen: Class of 2025 (1789)
Non-profit (1697)
Now hiring (4)
Obesity (40)
Opinion (29)
Ovarian cancer (30)
Pain (15)
Pancreatic cancer (29)
Parkinson's disease (39)
Partnered (4)
Patents (43)
Patient recruitment (34)
Peanut (12)
People (32322)
Phase I (5881)
Phase II (8487)
Phase III (5633)
Pipeline (190)
Policy (21)
Postmarket research (956)
Preclinical (3064)
Press Release (25)
Prostate cancer (28)
Psychedelics (8)
Radiopharmaceuticals (66)
Rare diseases (90)
Real estate (1274)
Recruiting (15)
Regulatory (2965)
Reports (3)
Research institute (1348)
Resumes & cover letters (23)
Rett syndrome (2)
RNA editing (1)
RSV (1)
Schizophrenia (9)
Series A (31)
Series B (19)
Sickle cell disease (16)
Spinal muscular atrophy (38)
Sponsored (6)
Startups (1104)
Stomach cancer (1)
Tariffs (3)
The Weekly (1)
Vaccines (204)
Venture capitalists (1)
Weight loss (22)
Women's health (6)
Worklife (2)
Date
Today (7)
Last 7 days (176)
Last 30 days (575)
Last 365 days (7014)
2025 (2249)
2024 (7476)
2023 (9246)
2022 (11480)
2021 (13223)
2020 (12764)
2019 (12112)
2018 (8980)
2017 (8685)
2016 (8883)
2015 (10228)
2014 (7801)
2013 (7578)
2012 (7533)
2011 (7545)
2010 (6766)
Location
Africa (262)
Alabama (11)
Alaska (3)
Arizona (38)
Arkansas (6)
Asia (10394)
Australia (2611)
California (1370)
Canada (418)
China (103)
Colorado (60)
Connecticut (65)
Delaware (30)
Europe (27744)
Florida (161)
Georgia (48)
Idaho (12)
Illinois (125)
India (3)
Indiana (61)
Iowa (2)
Japan (50)
Kansas (13)
Kentucky (4)
Louisiana (1)
Maine (13)
Maryland (149)
Massachusetts (870)
Michigan (38)
Minnesota (69)
Mississippi (1)
Missouri (20)
Montana (6)
Nebraska (4)
Nevada (13)
New Hampshire (8)
New Jersey (380)
New Mexico (8)
New York (394)
North Carolina (263)
North Dakota (2)
Northern California (647)
Ohio (68)
Oklahoma (5)
Oregon (9)
Pennsylvania (265)
Puerto Rico (1)
Rhode Island (12)
South America (288)
South Carolina (3)
Southern California (516)
Tennessee (25)
Texas (201)
United States (4910)
Utah (42)
Virginia (34)
Washington D.C. (18)
Washington State (137)
West Virginia (1)
Wisconsin (11)
171,134 Results for "cardiff university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
April 24, 2025
·
5 min read
Immutep Signs Exclusive License Agreement with Cardiff University for Next Generation Anti-LAG-3 Molecules for Cancer
Immutep Limited announces a License Agreement with Cardiff University granting the Company exclusive rights to develop and commercialise anti-LAG-3 small molecules.
June 25, 2024
·
4 min read
Press Releases
Cardiff Oncology to Present at Upcoming Investor Conferences
February 25, 2025
·
1 min read
Press Releases
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 15, 2025
April 16, 2025
·
1 min read
Press Releases
Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update
February 21, 2025
·
1 min read
Press Releases
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
April 15, 2025
·
4 min read
Press Releases
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
February 27, 2025
·
11 min read
Biotech Beach
Cardiff Oncology to Present at the Jefferies Healthcare Conference
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in a company presentation and 1x1 investor meetings at the Jefferies Healthcare Conference, which is taking place at the Marriott Marquis in New York from June 5-6, 2024.
May 29, 2024
·
1 min read
Biotech Beach
Cardiff Oncology to Present at Upcoming Investor Conferences in May 2024
Cardiff Oncology, Inc., a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, announced that company management will present at two upcoming investor conferences in May 2024.
May 13, 2024
·
1 min read
Business
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
Cardiff Oncology, Inc., a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, announced financial results for the first quarter ended March 31, 2024, and provided a business update.
May 2, 2024
·
12 min read
1 of 17,114
Next
